Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza+3 more
wiley +1 more source
Patient-reported outcomes for remote and in-person visits for genetic counseling in adult neurology. [PDF]
Paul RA+8 more
europepmc +1 more source
Effect of patient characteristics on reported outcomes after total knee replacement [PDF]
Antonio Escobar+6 more
openalex +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source
Longitudinal deteriorations in patient reported outcomes in patients with COPD [PDF]
Toru Oga+5 more
openalex +1 more source
Pericytes change function depending on glioblastoma vicinity: emphasis on immune regulation
Pericytes alter their transcriptome depending on their proximity to the tumor core. In the tumor core, pericytes display a more active state with higher communication strength but with lower immune activation potential and a shift toward extracellular matrix production.
Carolina Buizza+5 more
wiley +1 more source
Validity and Reliability of Clinical and Patient-Reported Outcomes in Multisystem Proteinopathy 1. [PDF]
Alfano LN+15 more
europepmc +1 more source
The Translation and Cultural Adaptation of Patient-Reported Outcome Measures
Stephen P. McKenna, Lynda Doward
openalex +1 more source
The impact of the Calman–Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patients [PDF]
Eva Morris+4 more
openalex +1 more source
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha+10 more
wiley +1 more source